Imperial College London Diabetes & Endocrine Centre (ICLDEC) has expanded [...]

Imperial College London Diabetes Centre, part of the M42 group, [...]

Japanese researchers discover a way to perform two different chemical [...]

Lilly has voiced strong support for the US administration’s goal [...]

Lungpacer Medical has received CMS New Technology Add-on Payment approval [...]

ScaleReady has awarded a $100,000 G-Rex grant to Sidra Medicine, [...]

James Anderson is the Chair of the INTREPID Alliance and the Executive Director of Global Health at the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a leading global organization representing pharmaceutical companies. In his role at IFPMA, James spearheads efforts to address critical global health challenges, including antimicrobial resistance, pandemic preparedness, and non-communicable diseases.

As debate continues over the cost and sustainability of GLP-1 [...]

Axplora has announced a €6.5 million investment at its Vizag [...]

Nucleus Network has acquired UK-based Hammersmith Medicines Research (HMR), a [...]